Lobe Sciences Ltd.
LOBEF · OTC
5/31/2025 | 2/28/2025 | 11/30/2024 | 8/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6 | $6 | $3 | $3 |
| - Cash | $8 | $0 | $0 | $0 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $1 | $8 | $5 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$1 | -$1 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$1 | -$1 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.005 | -0.004 | -0.005 | -0.018 |
| % Growth | -34.2% | 24% | 71.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |